Leigh Oliver’s practice is devoted to antitrust law, including counseling and litigation on a wide range of legal and policy issues relating to mergers and acquisitions, joint ventures, and competitor collaborations under federal and state antitrust laws. Leigh has extensive experience working on government investigations into prospective and post-consummated mergers and acquisitions, coordinating all aspects of multi-jurisdictional merger reviews and investigations, and handling non-merger government investigations. Leigh represents clients from a variety of industries, including healthcare, life sciences, aerospace and defense, energy, and entertainment. In the healthcare and life sciences area, she has represented pharmaceutical and medical device companies, healthcare providers, including hospitals, physicians, and clinical laboratories, and other ancillary providers, before federal and state antitrust enforcement agencies. She is a Vice Chair of the ABA Antitrust Section’s Transportation and Energy Committee and former Vice Chair of the Health Care and Pharmaceuticals Committee.
115
On 9 July 2021 President Biden signed a far-reaching executive order intended to promote competition in the American economy. The order targets perceived corporate consolidation and anticompetitive activity in the labor, financial services, health care, transportation, telecommunications, (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 144
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
